THROMBOTIC MICROANGIOPATHY Clinical Trial
Official title:
Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome
The aim of this study is to find the overall incidence of thrombotic microangiopathy in snakebite victims. As we know snakebite is a common in tropical regions. Many a times the early diagnosis of TMA is missed and precious time which could have helped in improving the patient prognosis is lost. Also via this study we wish to learn the role of cost effective test like peripheral smear which could help learn morphological picture of red blood cells and thus help in early prediction of patients clinical prognosis.
Status | Recruiting |
Enrollment | 81 |
Est. completion date | January 1, 2023 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - All patients with a history of snakebite and with prolonged WBCT. Exclusion Criteria: - Patients administered with blood or blood components prior to admission - Known case of bleeding disorders - Known case of haemolytic anaemia - Patients on antiplatelets or anticoagulants |
Country | Name | City | State |
---|---|---|---|
India | Jubilee Mission Medical College | Thrissur | Kerala |
Lead Sponsor | Collaborator |
---|---|
Jubilee Mission Medical College and Research Institute |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To find the number of peripheral smear samples of TMA snakebite in which schistocyte grading helps in predicting the patient clinical outcome | To find the number of PBS smears in which morphological evaluation of RBC in PBS examination helps in predicting clinical outcome in snakebite associated TMA | 1 year | |
Secondary | To find the number of hematotoxic snakebites associated with thrombotic microangiopathy (TMA) cases within 7days of admission | To find the number of TMA amongst snakebite victims in population coming to a tertiary care center in Kerala | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02604420 -
Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
|
||
Terminated |
NCT04743804 -
Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
|
Phase 3 | |
Terminated |
NCT00593229 -
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
|
N/A | |
Recruiting |
NCT05991245 -
French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"
|
||
Recruiting |
NCT04557735 -
Study of Ravulizumab in Pediatric Participants With HSCT-TMA
|
Phase 3 | |
Terminated |
NCT00726544 -
Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
|
Phase 2 | |
Recruiting |
NCT04543591 -
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
|
Phase 3 | |
Available |
NCT02355782 -
OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy
|
N/A |